Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127124761 | 12712476 | 1 | I | 20160813 | 20160822 | 20160902 | 20160902 | EXP | IT-MINISAL02-371999 | IT-BAYER-2016-164206 | BAYER | 85.00 | YR | E | M | Y | 0.00000 | 20160902 | CN | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127124761 | 12712476 | 1 | PS | Ciproxin 500 mg film-coated tablets | CIPROFLOXACIN | 1 | Oral | DAILY DOSE 1 G | 19537 | 1 | G | TABLET | |||||||
| 127124761 | 12712476 | 2 | SS | ALLOPURINOL. | ALLOPURINOL | 1 | Oral | DAILY DOSE 150 MG | 0 | 150 | MG | TABLET | |||||||
| 127124761 | 12712476 | 3 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Oral | DAILY DOSE 5 MG | 0 | 5 | MG | ||||||||
| 127124761 | 12712476 | 4 | C | ACETYLSALICYLIC ACID | ASPIRIN | 1 | Oral | DAILY DOSE 100 MG | 0 | 100 | MG | GASTRO-RESISTANT TABLET | |||||||
| 127124761 | 12712476 | 5 | C | ENTUMIN | CLOTHIAPINE | 1 | Oral | DAILY DOSE 10 GTT | 0 | 10 | GTT | ORAL DROPS, SOLUTION | |||||||
| 127124761 | 12712476 | 6 | C | KAYEXALATE | SODIUM POLYSTYRENE SULFONATE | 1 | Oral | DAILY DOSE 1 DF | 0 | 1 | DF | ||||||||
| 127124761 | 12712476 | 7 | C | CALCIUM SANDOZ [CALCIUM GLUCONATE] | 2 | Oral | DAILY DOSE 500 MG | 0 | 500 | MG | EFFERVESCENT TABLET | ||||||||
| 127124761 | 12712476 | 8 | C | NORMASE | 2 | Oral | DAILY DOSE 2 DF | 0 | 2 | DF | SYRUP | ||||||||
| 127124761 | 12712476 | 9 | C | PANTORC | PANTOPRAZOLE SODIUM | 1 | Oral | DAILY DOSE 20 MG | 0 | 20 | MG | GASTRO-RESISTANT TABLET | |||||||
| 127124761 | 12712476 | 10 | C | TAREG | VALSARTAN | 1 | Oral | DAILY DOSE 160 MG | 0 | 160 | MG | FILM-COATED TABLET | |||||||
| 127124761 | 12712476 | 11 | C | LASIX | FUROSEMIDE | 1 | Oral | DAILY DOSE 25 MG | 0 | 25 | MG | TABLET | |||||||
| 127124761 | 12712476 | 12 | C | CONTRAMAL | TRAMADOL HYDROCHLORIDE | 1 | Oral | DAILY DOSE 5 GTT | 0 | 5 | GTT | ORAL DROPS, SOLUTION | |||||||
| 127124761 | 12712476 | 13 | C | FOLACID | 2 | Oral | DAILY DOSE 5 MG | 0 | 5 | MG | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127124761 | 12712476 | 1 | Genitourinary tract infection |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127124761 | 12712476 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127124761 | 12712476 | Blister rupture | |
| 127124761 | 12712476 | Drug hypersensitivity | |
| 127124761 | 12712476 | Inflammation | |
| 127124761 | 12712476 | Rash vesicular | |
| 127124761 | 12712476 | Skin reaction |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127124761 | 12712476 | 1 | 20160811 | 20160812 | 0 | |
| 127124761 | 12712476 | 2 | 20160811 | 20160813 | 0 | |
| 127124761 | 12712476 | 4 | 20101110 | 0 | ||
| 127124761 | 12712476 | 6 | 20101110 | 0 | ||
| 127124761 | 12712476 | 10 | 20101110 | 0 |